• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network.印度学术急诊专家参与的印美联合工作组及OPUS12基金会关于创建一个协调、多学科、以患者为中心的全球即时护理生物标志物发现网络的共识声明。
Int J Crit Illn Inj Sci. 2014 Jul;4(3):200-8. doi: 10.4103/2229-5151.141398.
2
The 2015 Academic College of Emergency Experts in India's INDO-US Joint Working Group White Paper on Establishing an Academic Department and Training Pediatric Emergency Medicine Specialists in India.2015年印度学术急诊专家学院关于在印度设立学术部门并培训儿科急诊医学专家的印美联合工作组白皮书。
Int J Crit Illn Inj Sci. 2015 Oct-Dec;5(4):247-55. doi: 10.4103/2229-5151.170839.
3
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
4
The 2014 Academic College of Emergency Experts in India's INDO-US Joint Working Group (JWG) White Paper on "Developing Trauma Sciences and Injury Care in India".2014年印度应急专家学术委员会发布的印美联合工作组(JWG)关于“印度创伤科学与损伤护理发展”的白皮书。
Int J Crit Illn Inj Sci. 2014 Apr;4(2):114-30. doi: 10.4103/2229-5151.134151.
5
Academic College of Emergency Experts in India's INDO-US Joint Working Group (JWG) White Paper on the Integrated Emergency Communication Response Service in India: Much more than just a number!印度应急专家学术学院参与了印美联合工作组(JWG)关于印度综合应急通信响应服务的白皮书:远不止一个数字!
J Emerg Trauma Shock. 2013 Jul;6(3):216-23. doi: 10.4103/0974-2700.115354.
6
Critical Care Network in the State of Qatar.卡塔尔国重症监护网络。
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.
7
Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!阿巴斯·阿拉维:核医学领域的一位巨擘迎来80岁生日,依然精力充沛!
Hell J Nucl Med. 2018 Jan-Apr;21(1):85-87. doi: 10.1967/s002449910713. Epub 2018 Mar 20.
8
The "Case-Based Learning Conference" Model at EMINDIA2017: A Novel Implementation of Problem-Based Educational Paradigm.2017年印度医学教育会议上的“基于案例学习会议”模式:基于问题的教育范式的一种新实践
J Emerg Trauma Shock. 2018 Jan-Mar;11(1):61-64. doi: 10.4103/JETS.JETS_81_17.
9
Culture of Care: Organizational Responsibilities关怀文化:组织职责
10
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.首届卡塔尔重症监护会议及其《卡塔尔医学杂志》特刊——一个重要的里程碑。
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.

引用本文的文献

1
COVID-19 Blind Spots: A Consensus Statement on the Importance of Competent Political Leadership and the Need for Public Health Cognizance.新冠疫情盲点:关于胜任的政治领导力的重要性及公共卫生认知需求的共识声明
J Glob Infect Dis. 2020 Nov 30;12(4):167-190. doi: 10.4103/jgid.jgid_397_20. eCollection 2020 Oct-Dec.
2
The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper.2019 - 2020年新型冠状病毒(严重急性呼吸综合征冠状病毒2)大流行:美国学术国际医学学院 - 世界急诊医学学术理事会多学科COVID - 19工作组联合共识文件。
J Glob Infect Dis. 2020 May 22;12(2):47-93. doi: 10.4103/jgid.jgid_86_20. eCollection 2020 Apr-Jun.
3
Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission.新型冠状病毒(COVID-19):利用远程医疗优化护理,同时尽量减少暴露和病毒传播。
J Emerg Trauma Shock. 2020 Jan-Mar;13(1):20-24. doi: 10.4103/JETS.JETS_32_20. Epub 2020 Mar 19.
4
The "Case-Based Learning Conference" Model at EMINDIA2017: A Novel Implementation of Problem-Based Educational Paradigm.2017年印度医学教育会议上的“基于案例学习会议”模式:基于问题的教育范式的一种新实践
J Emerg Trauma Shock. 2018 Jan-Mar;11(1):61-64. doi: 10.4103/JETS.JETS_81_17.
5
A Novel Combination of Biomarkers to Herald the Onset of Sepsis Prior to the Manifestation of Symptoms.一种新型生物标志物组合,可在症状出现前预示败血症的发生。
Shock. 2018 Apr;49(4):364-370. doi: 10.1097/SHK.0000000000001010.
6
The Emergence of Zika Virus as a Global Health Security Threat: A Review and a Consensus Statement of the INDUSEM Joint working Group (JWG).寨卡病毒成为全球卫生安全威胁:INDUSEM联合工作组(JWG)的综述与共识声明
J Glob Infect Dis. 2016 Jan-Mar;8(1):3-15. doi: 10.4103/0974-777X.176140.
7
Advancing clinician-performed sonography in the twenty-first century: building on the rich legacy of the twentieth century pioneers.推动21世纪临床医生实施的超声检查:基于20世纪先驱者的丰富遗产。
Eur J Trauma Emerg Surg. 2016 Apr;42(2):115-8. doi: 10.1007/s00068-016-0652-y. Epub 2016 Mar 4.
8
Complications during intrahospital transport of critically ill patients: Focus on risk identification and prevention.重症患者院内转运期间的并发症:关注风险识别与预防。
Int J Crit Illn Inj Sci. 2015 Oct-Dec;5(4):256-64. doi: 10.4103/2229-5151.170840.
9
The Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond.2014 - 2015年埃博拉疫情:从协调多边行动到有效疾病控制、疫苗研发及其他
J Glob Infect Dis. 2015 Oct-Dec;7(4):127-38. doi: 10.4103/0974-777X.170495.
10
What's New in Critical Illness and Injury Science: The decades-long quest for a valid prognostic sepsis biomarker continues.危重病与损伤科学的新进展:对有效的脓毒症预后生物标志物长达数十年的探索仍在继续。
Int J Crit Illn Inj Sci. 2014 Oct-Dec;4(4):275-7. doi: 10.4103/2229-5151.147517.

本文引用的文献

1
Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).宫颈癌治疗的候选生物标志物:临床应用潜力(综述)
Mol Clin Oncol. 2014 Sep;2(5):647-655. doi: 10.3892/mco.2014.324. Epub 2014 Jun 23.
2
Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrast-induced nephropathy: a critical overview.即时检测血清肌酐设备用于检测造影剂肾病风险患者的准确性:批判性综述。
Crit Rev Clin Lab Sci. 2014 Dec;51(6):332-43. doi: 10.3109/10408363.2014.937794. Epub 2014 Jul 18.
3
Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis.白细胞介素-2用于潜伏性结核诊断的诊断准确性:一项系统评价与荟萃分析
Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2111-9. doi: 10.1007/s10096-014-2190-z. Epub 2014 Jul 4.
4
Burn resuscitation--hourly urine output versus alternative endpoints: a systematic review.烧伤复苏——每小时尿量与替代终点指标:一项系统评价
Shock. 2014 Oct;42(4):295-306. doi: 10.1097/SHK.0000000000000204.
5
Identifying cut points for biomarker defined subset effects in clinical trials with survival endpoints.在具有生存终点的临床试验中确定生物标志物定义的亚组效应的切点。
Contemp Clin Trials. 2014 Jul;38(2):333-7. doi: 10.1016/j.cct.2014.06.005. Epub 2014 Jun 16.
6
Challenges in managing amniotic fluid embolism: an up-to-date perspective on diagnostic testing with focus on novel biomarkers and avenues for future research.羊水栓塞管理中的挑战:关于诊断检测的最新观点,重点关注新型生物标志物及未来研究方向。
Curr Pharm Biotechnol. 2014;14(14):1168-78. doi: 10.2174/1389201015666140430163921.
7
Potential biomarkers and their applications for rapid and reliable detection of malaria.潜在生物标志物及其在疟疾快速可靠检测中的应用。
Biomed Res Int. 2014;2014:852645. doi: 10.1155/2014/852645. Epub 2014 Apr 2.
8
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers.微小RNA表达谱分析确定了一个由四种微小RNA组成的特征,作为三阴性乳腺癌中一种新型的诊断和预后生物标志物。
Oncotarget. 2014 Mar 15;5(5):1174-84. doi: 10.18632/oncotarget.1682.
9
Molecular imaging biomarkers for oncology clinical trials.肿瘤临床研究的分子影像生物标志物。
J Nucl Med. 2014 Apr;55(4):525-8. doi: 10.2967/jnumed.113.126128. Epub 2014 Mar 10.
10
Pancreatic stone protein - a possible biomarker of multiorgan failure and mortality in children sepsis.胰石蛋白——儿童脓毒症多器官功能衰竭和死亡率的一种可能生物标志物。
Cytokine. 2014 Apr;66(2):106-11. doi: 10.1016/j.cyto.2014.01.009. Epub 2014 Feb 13.

印度学术急诊专家参与的印美联合工作组及OPUS12基金会关于创建一个协调、多学科、以患者为中心的全球即时护理生物标志物发现网络的共识声明。

Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network.

作者信息

Stawicki Stanislaw P, Stoltzfus Jill C, Aggarwal Praveen, Bhoi Sanjeev, Bhatt Shashi, Kalra O P, Bhalla Ashish, Hoey Brian A, Galwankar Sagar C, Paladino Lorenzo, Papadimos Thomas J

机构信息

Department of Research and Innovation, Research Institute, Bethlehem, Pennsylvania ; Department of Research and Innovation, OPUS 12 Foundation Global, Columbus, USA.

Department of Research and Innovation, Research Institute, Bethlehem, Pennsylvania ; Department of Research and Innovation, Research Institute, Bethlehem, Pennsylvania.

出版信息

Int J Crit Illn Inj Sci. 2014 Jul;4(3):200-8. doi: 10.4103/2229-5151.141398.

DOI:10.4103/2229-5151.141398
PMID:25337481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4200545/
Abstract

Biomarker science brings great promise to clinical medicine. This is especially true in the era of technology miniaturization, rapid dissemination of knowledge, and point-of-care (POC) implementation of novel diagnostics. Despite this tremendous progress, the journey from a candidate biomarker to a scientifically validated biomarker continues to be an arduous one. In addition to substantial financial resources, biomarker research requires considerable expertise and a multidisciplinary approach. Investigational designs must also be taken into account, with the randomized controlled trial remaining the "gold standard". The authors present a condensed overview of biomarker science and associated investigational methods, followed by specific examples from clinical areas where biomarker development and/or implementation resulted in tangible enhancements in patient care. This manuscript also serves as a call to arms for the establishment of a truly global, well-coordinated infrastructure dedicated to biomarker research and development, with focus on delivery of the latest discoveries directly to the patient via point-of-care technology.

摘要

生物标志物科学给临床医学带来了巨大希望。在技术小型化、知识快速传播以及新型诊断技术的即时检验(POC)应用的时代,情况尤其如此。尽管取得了巨大进展,但从候选生物标志物到经过科学验证的生物标志物的历程仍然十分艰巨。除了大量资金资源外,生物标志物研究还需要相当多的专业知识和多学科方法。还必须考虑研究设计,随机对照试验仍然是“金标准”。作者简要概述了生物标志物科学及相关研究方法,随后列举了临床领域的具体实例,在这些领域中生物标志物的开发和/或应用切实改善了患者护理。本手稿还呼吁建立一个真正全球化、协调良好的基础设施,致力于生物标志物的研发,重点是通过即时检验技术将最新发现直接提供给患者。